
.../...
Sandoz seeks to bolster growth in what George calls emerging generic markets, including France, Italy and Japan, where lower use of copied drugs leaves room for growth. Generics made up 18 percent of drug sales volume in Japan in the year to March 31, while IMS Health Inc. estimates that such medicines account for about 63 percent of drugs prescribed in the U.S. (Ver...)
No hay comentarios:
Publicar un comentario